Sumatriptan

DrugBank ID: DB00669

Summary

Metric	Value
Total Predictions	51
KG+DL (Dual Validated)	3
DL Only	47
KG Only	1

Predictions

Indication	Score	Source
migraine disorder	0.9974	KG+DL
migraine with brainstem aura	0.9974	DL
atrophoderma vermiculata	0.9802	DL
ulerythema ophryogenesis	0.9683	DL
migraine with or without aura, susceptibility to	0.9673	DL
headache disorder	0.9327	DL
trigeminal autonomic cephalalgia	0.9294	DL
sciatic neuropathy	0.9244	DL
cluster headache syndrome	0.8773	KG+DL
tendinitis	0.8755	DL
obsolete vascular headache	0.8652	DL
idiopathic granulomatous myositis	0.8540	DL
myositis fibrosa	0.8540	DL
congenital hypotrichosis milia	0.8526	DL
myofascial pain syndrome	0.8462	DL
hemicrania continua	0.8448	KG+DL
hypotrichosis simplex of the scalp	0.8417	DL
diffuse alopecia areata	0.8415	DL
hypnic headache (disease)	0.8379	DL
SUNCT syndrome	0.8265	DL
fibromyalgia	0.8137	DL
inclusion body myositis	0.7745	DL
glossodynia	0.7409	DL
coccygodynia	0.7350	DL
alopecia	0.7250	DL
endogenous depression	0.6613	DL
dysthymic disorder	0.6603	DL
Ohdo syndrome and variants	0.6382	DL
major depressive disorder	0.6348	DL
oligospermia	0.5915	DL
osteoarthritis susceptibility	0.5776	DL
restless legs syndrome	0.5743	DL
nocturnal enuresis	0.5737	DL
obsolete rare pulmonary disease	0.5711	DL
Tourette syndrome	0.5693	DL
chronic pain syndrome	0.5614	DL
sudden arrhythmia death syndrome	0.5545	DL
myalgic encephalomeyelitis/chronic fatigue syndrome	0.5540	DL
scalp dermatosis	0.5501	DL
congenital cystic eye multiple ocular and intracranial anomalies	0.5476	DL
epidural abscess	0.5431	DL
ergotism	0.5366	DL
paramedian facial cleft	0.5365	DL
non-specific granulomatous orchitis	0.5363	DL
trichotillomania	0.5356	DL
psoriatic arthritis, susceptibility to, 1	0.5346	DL
tibial adamantinoma	0.5338	DL
Marin-Amat syndrome	0.5333	DL
inverse Marcus-Gunn phenomenon	0.5333	DL
benign neoplasm of trachea	0.5281	DL

Showing top 50 of 51 predictions.

External Links

Disclaimer
Predictions are for research purposes only and do not constitute medical advice.